Newsroom
  • June 22 , 2021

    Scientists discover novel oncogenic driver gene in human lung cancer

    A research team led by Prof. Wang Yuexiang from the Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences discovered a novel oncogenic driver gene in human lung cancer, the leading cause of cancer-related mortality worldwide.
    Read more
  • June 21 , 2021

    SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins

    A study published in PLOS Biology by Anna Heffron, Irene Ong and colleagues at the University of Wisconsin-Madison, U.S., suggests that immune responses may develop against other proteins produced by the SARS-CoV-2 virus.
    Read more
  • June 18 , 2021

    Next-generation T-cell therapeutics set sights on cancers, autoimmune disorders and more

    ​T cells—immune cells that patrol our bodies in search of trouble—have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells themselves as a form of medicine.
    Read more
  • June 17 , 2021

    Most cancer cells grown in a dish have little in common with cancer cells in people

    In a bid to find or refine laboratory research models for cancer that better compare with what happens in living people, Johns Hopkins Medicine scientists report they have developed a new computer-based technique showing that human cancer cells grown in culture dishes are the least genetically similar to their human sources.
    Read more
  • June 16 , 2021

    Scientists are deciphering the details of immune cell activation

    Chemokine receptors, located at the surface of many immune cells, play an important role in cell function. Chemokines are small proteins that bind to these receptors and control the movement and behavior of white blood cells.
    Read more
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
If you would like to get in touch with us, please click here. Contact us